HDL in diabetic breast cancer patients in contrast to nondiabetic patients may promote migration and invasion in both ER/PgR positive and PgR/ER receptor negative breast cancer through ERK and p38 MAPK pathways [29, 57]. This evidence concerns the gene ESR1 and breast cancer.